Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
Schiller
Ampronix

Vascular Brain Injury Greater Risk Factor Than Amyloid Plaques in Cognitive Aging Processes

By Medimaging International staff writers
Posted on 27 Feb 2013
Vascular brain injury from disorders such as stroke and high blood pressure are greater risk factors for cognitive impairment among nondemented older individuals than is the amyloid plaques accumulation of the brain that long have been implicated in conditions such as Alzheimer’s disease (AD), new findings have revealed.

Published online February 11, 2012, in JAMA Neurology (formerly Archives of Neurology), the study found that vascular brain injury had by the greatest influence across a variety of cognitive domains, including the forgetfulness of mild cognitive decline and higher-level thinking.

The researchers in addition tried to determine whether there was a link between vascular brain injury and the deposition of beta amyloid (Αβ) plaques, thought to be an early and important marker of Alzheimer’s disease, said Bruce Reed, associate director of the University of California (UC) Davis Alzheimer’s Disease Research Center (Martinez, CA, USA). They also attempted to decode what effect each has on memory and executive functioning.

“We looked at two questions,” said Dr. Reed, professor in the department of neurology at UC Davis. “The first question was whether those two pathologies correlate to each other, and the simple answer is ‘no.’ Earlier research conducted in animals, has suggested that having a stroke causes more beta amyloid deposition in the brain. If that were the case, people who had more vascular brain injury should have higher levels of beta amyloid. We found no evidence to support that. The second was whether higher levels of cerebrovascular disease or amyloid plaques have a greater impact on cognitive function in older, nondemented adults. Half of the study participants had abnormal levels of beta amyloid and half vascular brain injury, or infarcts. It was really very clear that the amyloid had very little effect, but the vascular brain injury had distinctly negative effects. The more vascular brain injury the participants had, the worse their memory and the worse their executive function--their ability to organize and problem solve.”

The research was performed in 61 male and female study participants who ranged in age from 65 to 90 years old, with a median age of 78. Thirty of the participants were clinically “normal,” 24 were cognitively impaired, and seven were diagnosed with dementia, based on cognitive testing. The participants had been recruited from Northern California between the years 2007 to 2012.

The study participants underwent magnetic resonance imaging (MRI)—to measure vascular brain injury—and positron emission tomography (PET) scans to measure beta amyloid deposition: markers of the two most common pathologies that affect the aging brain. Vascular brain injury emerges as brain infarcts and white matter hyperintensities in MRI scans, regions of the brain that appear bright white.

The study demonstrated that both memory and executive function correlated negatively with brain infarcts, particularly infarcts in cortical and subcortical gray matter. Although infarcts were typical in this group, the infarcts varied greatly in size and location, and many had been clinically silent. The level of amyloid in the brain did not correlate with either alterations in executive function or memory, and there was no signs that amyloid interacted with infarcts to impair thinking.

According to Dr. Reed, the research is significant because there is a vast amount of interest in detecting AD at its earliest stage, before an individual shows clinical symptoms. It is possible to perform a brain scan and identify beta amyloid in the brain, and that is a very new advance, he noted.

“The use of this diagnostic tool will become reasonably widely available within the next couple of years, so doctors will be able to detect whether an older person has abnormal levels of beta amyloid in the brain. So it’s very important to understand the meaning of a finding of beta amyloid deposition,” Dr. Reed said. “What this study says is that doctors should think about this in a little more complicated way. They should not forget about cerebrovascular disease, which is also very common in this age group and could also cause cognitive problems. Even if a person has amyloid plaques, those plaques may not be the cause of their mild cognitive symptoms.”

Related Links:

University of California, Davis




Channels

Radiography

view channel

New Patient-Centered Tool Devised to Record Side Effects of Radiotherapy

Researchers have investigated a patient-centered approach to evaluating the side effects of radiotherapy and have shown that it may be able to optimize the detection and management of treatment-related toxicity. For lung tumors that cannot be removed with surgery, radiotherapy is the best treatment option.... Read more

Ultrasound

view channel

Guidelines Released for Quantitative Monitoring of Critically Ill and Surgery Patients Using Echocardiography

The American Society of Echocardiography (ASE; Morrisville, NC, USA) has published clinical guidelines describing how and when echocardiography can be used for medical and surgical therapy in adult patients. The guidelines were published in the January 2015 issue of the American Society of Echocardiography.... Read more

Nuclear medicine

view channel
Image: Created by averaging PET scan data from chronic pain patients (left) and healthy controls (right), the images reveal higher levels of inflammation-associated translocator protein (orange/red) in the thalamus and other brain regions of chronic pain patients (Photo courtesy of Marco Loggia, Martinos Center for Biomedical Imaging, Massachusetts General Hospital).

PET/MR Imaging Shows First Evidence of Neuroinflammation in Chronic Pain Patients’ Brains

For the first time, researchers have used neuroimaging strategies to find evidence of neuroinflammation in major regions of the brains of patients with chronic pain. By showing that levels of an i... Read more

General/Advanced Imaging

view channel
Image: Dr. Miles was part of the team that helped identify facial measurements in children with autism that may lead to a screening tool for young children and provide clues to its genetic causes (Photo courtesy of Rebecca F. Miller).

Advanced 3D Facial Imaging Designed to Help in Early Identification of Autism

Autism is a range of closely related disorders observed in patients who exhibit a shared assortment of symptoms, including delays in learning to communicate and interrelate socially. Early detection of... Read more

Imaging IT

view channel

Potential Cost of Data Breaches of Protected Health Information Could Reach USD 5.6 Billion Annually

The healthcare industry and institutions face an ever-increasing threat of data breaches to clinical and patient information. Cybercriminals are attracted to Protected Health Information (PHI) such as Social Security Numbers (SSN) on Medicare cards, and other sensitive medical information stored online on an institutions'... Read more

Industry News

view channel

New Strategic Partnership Agreement for Surgical Displays

An agreement between Barco (Kortrijk, Belgium), a visualization products company, and Medical Computers Deutschland (MCD; Moenchengladbach, Germany), a supplier of customized Healthcare IT (Information Technology) solutions, covers the sale of surgical displays for the healthcare industry in Germany, Austria, and Switzerland.... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.